Enhancement of the immune response of a novel DNA vaccine encoding conserved NS3 and Core fusion gene of HCV injected by intradermal electrotransfer in mice

Chinese Journal of Microbiology and Immunology

Volumn 30, Issue 1, 2010, Pages 41-45

  Yin, Xiao ^a   Lu, Jian ^b   Tan, Wen Jie ^a,b   Deng, Yao ^b   Guan, Jie ^b   Tian, Rui Guang ^b   Wang, Wen ^b   Chen, Hong ^b   Bi, Sheng Li ^b   Ruan, Li ^b  

^a State Key Laboratory for Molecular Virology and Genetic Engineering   (China)

^b NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

Author keywords

DNA vaccine; Hepatitis C virus (HCV); Intradermal electrotransfer

Indexed keywords

CORE PROTEIN; DNA VACCINE; GAMMA INTERFERON; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 3 CORE PROTEIN FUSION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS C; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENETICS; MOUSE; NONHUMAN;

EID: 84863230102     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0254-5101.2010.01.012     Document Type: Article

References (17)

1. Dustin L B, Rice C M. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol, 2007, 25: 71-99.
2. Houghton M, Abrignani S. Prospects for a vaccine against the hepatitis C virus. Nature, 2005, 436(7053): 961-966.
3. 2006, 26(10): 64-70.
4. Folgori A, Capone S, Ruggeri L, et al. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med, 2006, 12(2): 190-197.
5. Diepolder H M, Zachoval R, Hoffmann R M, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet, 1995, 346(8981): 1006-1007.
6. Lemieux P. Technological advances to increase immunogenicity of DNA vaccines. Expert Rev Vaccines, 2002, 1(1): 85-93.
7. Zampaglione I, Arcuri M, Cappelletti M, et al. In vivo DNA gene electro-transfer: a systematic analysis of different electrical parameters. J Gene Med, 2005, 7(11): 1475-1481.
8. Jiao X, Wang R Y, Feng Z, et al. DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response. J Viral Hepat, 2004, 11(1): 18-26.
9. Isaguliants M G, Petrakova N V, Mokhonov W, et al. DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus. Immunol Lett, 2003, 88(1): 1-13.
10. + T cells. J Immunol, 2007, 179(7):4741-4753
11. 1993, 9(2): 114-126.
12. Barouch D H, Yang Z Y, Kong W P, et al. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates. J Virol, 2005, 79(14): 8828-8834.
13. Frelin L, Alheim M, Chen A, et al. Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo. Gene Ther, 2003, 10(8): 686-699.
14. McGivern D R, Lemon S M. Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. Annu Rev Pathol, 2009, 4: 399-415.
15. Bode J G, Brenndörfer E D, Häussinger D. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response. Biol Chem, 2008, 389(10): 1283-1298.
16. Capone S, Zampaglione I, Vitelli A, et al. Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates. J Immunol, 2006, 177(10): 7462-7471.
17. Tjelle T E, Salte R, Mathiesen I, et al. A novel electroporation device for gene delivery in large animals and humans. Vaccine, 2006, 24(21): 4667-4670.